Patent · US Active

SEMA3B inhibits tumor growth and induces apoptosis in cancer cells

US7781413B2 · kind B2 · utility

3Cited by
3References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2002
Grant dateAug 24, 2010
Priority date
Expiry dateSep 2, 2026

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/57484
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention identifies the semaphorin polypeptide SEMA3B as a tumor suppressor. This molecule can inhibit tumor growth and induce apoptosis of tumor cells when produced internally in a cancer cell via gene transfer, or when applied extracellularly. These observations permit new methods for treatment and diagnosis of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.